MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with E

Eletriptan

Eletriptan 20mg tablets

No stability information

Stability notes for Eletriptan 20mg tablets

There are no stability notes for this medicine.

Suppliers (6) of Eletriptan 20mg tablets
Eletriptan 20mg tablets (A A H Pharmaceuticals Ltd)
Eletriptan 20mg tablets (Alliance Healthcare (Distribution) Ltd)
Eletriptan 20mg tablets (Consilient Health Ltd)
Eletriptan 20mg tablets (Zentiva Pharma UK Ltd)
Relpax 20mg tablets (Sigma Pharmaceuticals Plc)
Relpax 20mg tablets (Viatris UK Healthcare Ltd)

Eletriptan 40mg tablets

No stability information

Stability notes for Eletriptan 40mg tablets

There are no stability notes for this medicine.

Suppliers (7) of Eletriptan 40mg tablets
Eletriptan 40mg tablets (A A H Pharmaceuticals Ltd)
Eletriptan 40mg tablets (Alliance Healthcare (Distribution) Ltd)
Eletriptan 40mg tablets (Consilient Health Ltd)
Eletriptan 40mg tablets (Zentiva Pharma UK Ltd)
Relpax 40mg tablets (CST Pharma Ltd)
Relpax 40mg tablets (Necessity Supplies Ltd)
Relpax 40mg tablets (Viatris UK Healthcare Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.